InvestSMART

Betashares Global Healthcare ETF - Currency Hedged (ASX: DRUG) - Share Price and Research

Current share price for DRUG : $8.500 0.04 (0.47%)+

Betashares Global Healthcare ETF - Currency Hedged (DRUG) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Betashares Global Healthcare ETF -Currency Hedged (DRUG) provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector. The Fund aims to track the performance of an index (before fees and expenses) which provides exposure to the performance of the largest global healthcare companies by market capitalization (excluding companies in Australia), hedged into Australian dollars.

DRUG General Information +

ASX Code DRUG
Website http://www.betashares.com.au
Industry/Sector Asset Management & Custody Banks
Market Cap ($M) 191
DRUG Share Price $8.500
Day High $8.520
Day Low $8.470
Last Close $8.460
DRUG Share Price Movement $0.04 ( 0.47% )
Prices as at 16:40, 8 Nov 2024
+Security prices are delayed by at least 20 minutes and are indicative only.

DRUG Fund Information

Equity World Other
MSCI World Ex Australia NR AUD
Not Rated
Not Rated
Investment Fund
4 Aug 2016
$191.97 million (as at 1 Nov 2024)

DRUG ETF performance (31 Oct 2024)

NOTE : returns for periods greater than 1 year are annualised
  1 Month % 3 Month % 6 Month % 1 Year % p.a. 2 Year % p.a. 3 Year % p.a. 5 Year % p.a. 10 Year % p.a.
Total return -4.15 -3.21 3.77 17.4 6.5 3.96 8.46 -
Growth return -4.15 -3.21 1.11 - 4.78 2.76 6.45 -
Income return (Yield) 0 0 2.66 - 1.72 1.2 2.01 -

Market index (MSCI World Ex Australia NR AUD)

Total return 3.92 2.14 10.2 29.31 20.19 11.39 13.27 13.18

DRUG Related Research

Betashares Global Healthcare ETF - Currency Hedged (DRUG) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 22.3¢ 0% 1 Jul 2024 16 Jul 2024 $8.500 $8.490 -
Result 2.67¢ 0% 2 Jan 2024 17 Jan 2024 $8.500 $8.490 -
Result 2.62¢ 0% 3 Jan 2023 18 Jan 2023 $8.500 $8.490 -

See all dividends from Betashares Global Healthcare ETF - Currency Hedged (DRUG) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Betashares Global Healthcare ETF - Currency Hedged (DRUG) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Betashares Global Healthcare ETF - Currency Hedged (DRUG) Financials $192 Units on Issue Disclosure - October 2024 6 Nov 2024 12:07PM $8.500 $8.500 fallen by 0%
Betashares Global Healthcare ETF - Currency Hedged (DRUG) Financials $192 Units on Issue Disclosure - September 2024 4 Oct 2024 12:56PM $8.760 $8.500 fallen by 2.97%
Betashares Global Healthcare ETF - Currency Hedged (DRUG) Financials $192 Annual Report 27 Sep 2024 4:17PM $8.860 $8.500 fallen by 4.06%
Betashares Global Healthcare ETF - Currency Hedged (DRUG) Financials $192 Units on Issue Disclosure - August 2024 5 Sep 2024 2:57PM $9.090 $8.500 fallen by 6.49%
Betashares Global Healthcare ETF - Currency Hedged (DRUG) Financials $192 Units on Issue Disclosure - July 2024 6 Aug 2024 5:34PM $8.620 $8.500 fallen by 1.39%
Betashares Global Healthcare ETF - Currency Hedged (DRUG) Financials $192 Estimated Annual Distribution Component Information 8 Jul 2024 3:05PM n/a $8.500 n/a

DRUG Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2024A $18.93 $93.30 169.40% 8.70 25.00 3.10% 0.0%
2023A $6.99 $34.60 366.60% 22.10 2.60 0.30% 0.0%
2022A $1.57 $7.40 -92.80% 103.70 1.90 0.30% 0.0%

DRUG Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2022 A 2023 A 2024 A 2022 A 2023 A 2024 A 2022 A 2023 A 2024 A
Betashares Global Healthcare ETF - Currency Hedged (DRUG) $191M 1.6941 0.0000 0.0000 9.0704 0.0000 0.0000 2.95% 0.00% 0.00%
HMC Capital (HMC) $4,267M 0.0191 0.0000 0.0000 49.6165 0.0000 0.0000 1.16% 0.00% 0.00%
Netwealth Group (NWL) $7,013M 0.2382 0.2683 0.2210 84.0176 66.2428 54.2511 0.98% 1.23% 1.49%
Pinnacle Investment Management Group (PNI) $4,181M 0.1667 0.1969 0.1911 45.2308 37.7892 31.7250 2.04% 2.38% 2.84%
Perpetual (PPT) $2,359M -0.1521 0.2241 -0.0452 14.5030 11.8479 12.4089 5.73% 6.31% 5.83%

DRUG Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 9.11 1.00 0.00
Market 0.48 14.10 1.09 0.91
Sector 0.00 0.00 0.00 0.00

DRUG Directors

Name Position Start Date
Mr Alex Vynokur Executive Director 21 Sep 2009
Mr Jason Gellert Executive Director 5 Mar 2021
Mr Edward Sippel Non-Executive Director 5 Mar 2021

Betashares Global Healthcare ETF - Currency Hedged (DRUG) Changes in Directors' Interest & Trades

There are no directors' trades from Betashares Global Healthcare ETF - Currency Hedged (DRUG). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

FAQs about Betashares Global Healthcare ETF - Currency Hedged (DRUG)

Betashares Global Healthcare ETF - Currency Hedged's (DRUG) current share price is $8.50. This constitutes a price movement of 0.12% when compared to the share price 7 days ago and is -7.21% below DRUG's 12-month high of $9.16 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $8.46, Betashares Global Healthcare ETF - Currency Hedged's (DRUG) current share price of $8.50 constitutes a movement of $0.04 or 0.47%. Betashares Global Healthcare ETF - Currency Hedged's (DRUG) share price movement is 0.12% when compared to 7 days ago and is -7.21% below DRUG's 52-week high of $9.16.

Betashares Global Healthcare ETF - Currency Hedged's (DRUG) 52-week high is $9.16 which was reached on 2 Sep 2024. Relative to this, DRUG's current share price of $8.50 constitutes a -$0.66 or -7.21% drop since that high of $9.16 per DRUG share.

Betashares Global Healthcare ETF - Currency Hedged's (DRUG) 52-week low is $7.48 which was reached on 10 Nov 2023. Relative to this, DRUG's current share price of $8.50 constitutes a $1.02 or 13.64% gain since that low of $7.48 per DRUG share.

Betashares Global Healthcare ETF - Currency Hedged's (DRUG) current market capitalisation is $191,615,679. Market capitalisation, sometimes referred to as "market cap", is the total value of a company's or ETF's issued shares or units owned by shareholders or unitholders. Market capitalisation is equal to the market price per share or unit multiplied by the number of shares or units outstanding.

Betashares Global Healthcare ETF - Currency Hedged (DRUG) last distribution or dividend was $0.22 per share and was paid on 16 Jul 2024. This last DRUG distribution or dividend included 0% franking.

Upcoming ex-distribution date: 1 Jul 2024

Upcoming record date: 2 Jul 2024

Upcoming payment date: 16 Jul 2024

ETFs, such as Betashares Global Healthcare ETF - Currency Hedged (DRUG), pay distributions instead of dividends. The difference is that dividends are declared by companies from part of the profits made during any given year and the company’s management decide the amount of earnings retained verses how much to pay out to investors. An ETF, like Betashares Global Healthcare ETF - Currency Hedged (DRUG), must pay out all realised income. This is a combination of any dividends received plus capital gains realised from the buying and selling of underlying holdings within Betashares Global Healthcare ETF - Currency Hedged (DRUG).


A distribution has three key dates:

Ex-distribution date: Date the distribution value leaves the ETF. This will normally correspond with the ETF unit price dropping in value by the same amount as the distribution.

Record date: Date someone must be on the unit registry to receive the distribution.

Payment date date: Date the distribution is paid to the unit holder.

Betashares Global Healthcare ETF - Currency Hedged (DRUG) has a franking level of 0%. Franking represents the tax a company has already paid on any profit it distributes to shareholders as a dividend. Only Australian companies pay franking credits therefore you will not see franking on ETFs that invest internationally. For ETFs that are diversified across asset classes, you may see partial franking.

Betashares Global Healthcare ETF - Currency Hedged (DRUG) has a current dividend yield of 2.80% this year. Last year's dividend yield was 0.30%. The dividend yield for DRUG is a ratio that tells you the percentage of Betashares Global Healthcare ETF - Currency Hedged (DRUG)'s share price that it pays out in dividends each year. The dividend yield is calculated by dividing the annual dividends by the current share price.

The "management expense ratio" (MER) for Betashares Global Healthcare ETF - Currency Hedged (DRUG) is 0.57%. This is the total expense for operating an ETF or managed fund like Betashares Global Healthcare ETF - Currency Hedged (DRUG). This includes management fees and other operating expenses which all come out of an investor's return.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.